Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Feb 14, 2015; 21(6): 1838-1844
Published online Feb 14, 2015. doi: 10.3748/wjg.v21.i6.1838
Table 1 Correlation of fibroblast growth factor receptor 4 expression with clinicopathological characteristics n (%)
Clinicopathological characteristicsnFGFR4 positiveFGFR4 negativeχ2P value
17577 (44.00)98 (56.00)
Gender0.11400.8663
Male12556 (44.8)69 (55.20)
Female5021 (42.00)29 (58.00)
Age (yr)0.92111.0000
< 607232 (44.44)40 (55.56)
≥ 6010345 (43.69)58 (56.31)
Tumor size0.14000.1518
≤ 3 cm6031 (51.67)29 (48.33)
> 3 cm11546 (40.00)69 (60.00)
Tumor location1.39420.4980
U3217 (53.13)15 (46.88)
M7129 (40.85)42 (59.15)
L7231 (43.06)41 (56.94)
Tumor differentiation0.21910.1129
Poor7629 (38.16)47 (61.84)
Well9948 (48.48)51 (51.52)
Macroscopic type
EGC218 (38.10)13 (61.90)9.38420.0522
I93 (33.33)6 (66.67)
II53 (60.00)2 (40.00)
III12762 (48.82)65 (51.18)
IV131 (7.69)12 (92.31)
TNM stages0.34990.9504
I3715 (40.54)22 (59.46)
II4521 (46.67)24 (53.33)
III6930 (43.48)39 (56.52)
IV2411 (45.83)13 (54.17)
T0.95230.8128
1218 (38.10)13 (61.90)
22914 (48.28)15 (51.72)
36430 (46.88)34 (53.13)
46125 (40.98)36 (59.02)
N1.81600.6115
05527 (49.09)28 (50.91)
13211 (34.38)21 (65.63)
22411 (45.83)13 (54.17)
36428 (43.75)36 (56.25)
M0.03791.0000
015166 (43.71)85 (56.29)
12411 (45.83)13 (54.17)
Neural invasion0.75760.5146
Yes259 (36.00)16 (64.00)
No15068 (45.33)82 (54.67)
Vascular invasion0.44730.2356
Yes3513 (37.14)22 (62.86)
No14064 (45.71)76 (54.29)
P533.09410.3773
07237 (51.39)35 (48.61)
14316 (37.21)27 (62.79)
2207 (35.00)13 (65.00)
34017 (42.50)23 (57.50)
P270.99240.8031
08737 (42.53)50 (57.47)
17234 (47.22)38 (52.78)
2124 (33.33)8 (66.67)
342 (50.00)2 (50.00)
Topo IIα9.47600.0236
08329 (34.94)54 (65.06)
16631 (46.97)35 (53.03)
22514 (60.87)9 (39.13)
333 (100)0 (0)